Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,806 | 242 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $631.27 | 52 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $464.47 | 34 | $0 (2020) |
| Alkermes, Inc. | $436.32 | 37 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $324.95 | 34 | $0 (2019) |
| Allergan Inc. | $215.46 | 39 | $0 (2019) |
| Lundbeck LLC | $181.42 | 11 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.41 | 8 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $77.81 | 4 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $68.39 | 4 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $58.85 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $99.86 | 6 | Janssen Pharmaceuticals, Inc ($37.54) |
| 2019 | $925.64 | 100 | Janssen Pharmaceuticals, Inc ($224.72) |
| 2018 | $1,033 | 84 | Otsuka America Pharmaceutical, Inc. ($238.71) |
| 2017 | $747.32 | 52 | Otsuka America Pharmaceutical, Inc. ($149.03) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/03/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: CNS | ||||||
| 02/25/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: PSYCHIATRY | ||||||
| 02/18/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Neuroscience | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Neuroscience | ||||||
| 01/28/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: PSYCHIATRY | ||||||
| 01/14/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/31/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: CNS | ||||||
| 12/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Neuroscience | ||||||
| 11/26/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Neuroscience | ||||||
| 11/19/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: Neuroscience | ||||||
| 10/31/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: Neuroscience | ||||||
| 10/23/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Central Nervous System | ||||||
| 10/15/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 191 | 456 | $69,462 | $21,737 |
| 2022 | 7 | 290 | 922 | $133,493 | $40,706 |
| 2021 | 7 | 311 | 926 | $128,904 | $44,578 |
| 2020 | 7 | 362 | 1,104 | $158,077 | $48,791 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 73 | 244 | $28,060 | $8,850 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 136 | $25,024 | $7,851 | 31.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $7,826 | $2,359 | 30.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 38 | $6,308 | $2,017 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,244 | $660.00 | 29.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 98 | 470 | $79,430 | $24,300 | 30.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 74 | 309 | $28,119 | $8,620 | 30.7% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 35 | 41 | $7,011 | $2,033 | 29.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $5,742 | $1,714 | 29.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 21 | $5,103 | $1,551 | 30.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 25 | $4,250 | $1,288 | 30.3% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 22 | 38 | $3,838 | $1,199 | 31.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 98 | 433 | $67,548 | $23,426 | 34.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 101 | 373 | $31,365 | $10,706 | 34.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 29 | $8,526 | $2,978 | 34.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $7,812 | $2,728 | 34.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 32 | 37 | $5,809 | $2,008 | 34.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 21 | 23 | $4,945 | $1,715 | 34.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 13 | $2,899 | $1,017 | 35.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 82 | 356 | $62,300 | $19,750 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 93 | 535 | $50,825 | $16,076 | 31.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 47 | 56 | $9,800 | $3,069 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 25 | $8,275 | $2,641 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 87 | $12,267 | $2,606 | 21.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 27 | 30 | $7,320 | $2,328 | 31.8% |
About Dr. Leonard Richards, DO
Dr. Leonard Richards, DO is a Psychiatry healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548249311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Richards, DO has received a total of $2,806 in payments from pharmaceutical and medical device companies, with $99.86 received in 2020. These payments were reported across 242 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,806).
As a Medicare-enrolled provider, Richards has provided services to 1,154 Medicare beneficiaries, totaling 3,408 services with total Medicare billing of $155,812. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Des Moines, IA
- Active Since 01/11/2006
- Last Updated 09/06/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1548249311
Products in Payments
- REXULTI (Drug) $371.19
- ABILIFY MAINTENA (Drug) $355.55
- LATUDA (Drug) $324.95
- Aristada 441 mg (Drug) $270.78
- VRAYLAR (Drug) $213.46
- SPRAVATO (Drug) $203.89
- INVEGA SUSTENNA (Drug) $183.67
- ARISTADA (Drug) $165.54
- Trintellix (Drug) $148.31
- AUSTEDO (Drug) $77.81
- INVEGA TRINZA (Drug) $76.91
- TRINTELLIX (Drug) $69.67
- Fanapt (Drug) $68.39
- NUPLAZID (Drug) $47.58
- INGREZZA (Drug) $40.79
- APLENZIN (Drug) $33.12
- Entyvio (Biological) $31.95
- VYVANSE (Drug) $24.32
- BELSOMRA (Drug) $23.88
- MYDAYIS (Drug) $19.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Des Moines
Dr. Manmohan Singh, Md, MD
Psychiatry — Payments: $595,970
Dr. Thomas Koithan, Do, DO
Psychiatry — Payments: $7,961
Cynthia Coenen, Arnp/Pmhnp-Bc, ARNP/PMHNP-BC
Psychiatry — Payments: $5,982
Dr. J Patrick Bertroche, D.o, D.O
Psychiatry — Payments: $680.34
Dr. Martin Fialkov, M.d, M.D
Psychiatry — Payments: $538.08
Dr. Ketan Dhadphale, M.d, M.D
Psychiatry — Payments: $526.17